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Anisomycin is an effective inhibitor of cerebral protein synthesis in mice and is also an effective amnestic agent for both passive and active behavioral tasks. From use of anisomycin in combination with a variety of stimulant and depressant drugs, we conclude that the level of arousal following acquisition plays an important role in determining the duration and the rate of the biosynthetic phase of memory formation. While we have interpreted the experiments with anisomycin as evidence for an essential role of protein in memory storage, others have suggested that side effects of inhibitors of protein synthesis on catecholamine metabolism are the main cause of amnesia. Several experiments were therefore done to compare the effects of anisemycin and catecholamine inhibitors on memory. We conclude that anisomycin's principal amnestic mechanism does not involve inhibition of the catecholamine system. '!he results strengthen our conclusion that protein synthesis is an essential component for ~ongterm memory trace formation. Also, it is suggested that proteins synthesized in the neuronal cell body are used, in conjunction with other molecules, to produce permanent and semi-permanent anatomical changes.
The search for the elusive memory trace has long intrigued scientists, but until approximately 1950 research in this field was primarily limited to anatomists such as Raymon y cajal or psychologists such as D. O. Hebb. In 1950 Katz and Halstead (1) proposed a chemical theory of memory when they suggested that "an essential feature in the genesis of the memory trace is the formation, as a result of individual experience, of geometrically ordered protein molecules in the neurons t 6f the.cerebrum. These new ordered molecules then function as template molecules . and thus now have the same relationship to the cell as do the original genes." With the discovery in the early 1950's of the double-helical structure of DHA and the evolving theories of RNA in information processing, investigation of the involvement of macromolecules in memory began in earnest. At that time, a few scientists, notably Professor Holger Hyden, began e~~riments on possible changes in RNA associated with the training of the laboratory rat. His studies, which have continued to the present, served as the catalyst for numerous attempts to demonstrate the elusive role of nucleic acids in memory. Out of these studies, it is generally accepted that increased RNA synthesis occurs during and shortly after training, but not too much more can be said of the role of this RNA in memory-trace formation except in general terms that it leads to the synthesis of new protein.
The presumed involvement of proteins in the formation of long-term memory naturally led to experiments to test this relationship. In the early 1960's, the Flexners initiated-an approach which, with refinements, is still in use. This approach will be the main focus of this paper.
The Flexners began their classic experiments with the inhibitor of protein synthesis, puromycin. They showed that puromycin, when injected intracerebrally into the mouse, led to amnesia for a recently learned task. It was suggested that the maintenance of memory depends upon the continuing synthesis of protein (2) . The initial reports of the Flexners encouraged others to investigate the possible relationship of protein synthesis to long-term memory formation, and during the remainder of the 1960's it was shown that other inhibitors of protein synthesis would produce amnesia in a variety of species including goldfish, mouse, and rat if administered shortly before or after training. Nevertheless, problems of interpretation still remained, and many investigators in this field have been or are still unwilling to agree that the experiments with protein synthesis inhibitors have demonstrated a crucial role for protein in memory trace formation.
Each of the inhibitors of protein synthesis being used at that time--puromycin, cycloheximide and acetoxycycloheximide--had certain disadvantages. Puranycin had to be injected intracerebrally, and further research showed that it leads to hippocampal seizures in the mouse. It also produces changes in the concentration and turnover of catecholamines and has been shown to produce a long-lasting peptidyl-puromycin. For all of these and other reasons, the Flexners are still hesitant to c~nclude that experiments with puromycin have demonstrated a requirement for protein synthesis to establish long-term memory (3) . Cycloheximide had to be used at near toxic doses in the mouse in order to obtain 80% or more inhibition of protein synthesis lasting about 2 hours. This limited experimental flexibility and also raised questions of interpretation. Acetoxycycloheximide, which was much more potent and produced a much longer inhibition of protein synthesis, became unavailable.
It was \\li th tilese concerns in mind that approximately 1970 we b2Qan a search for another inhibitor of cerebral protein synthesis--one that would not show many of the disadvantages cited above. Rather fortuitously we found one--anisomycin (ANI) (4) . ANI is a relatively simple pyrollidine derivative isolated from a streptemyces. It is a IX>tent inhibitor of protein synthesis through its interference with transpeptidation (5).
In the rrouse, we found that subcutaneous injections of ANI at a dosage of 20 mg/kg inhibited protein synthesis by at least 80% for approximately 2 hours. Also, ANI was relatively non-toxic in the rrouse and injections could be repeated many times. Thus, the duration and time course of inhibition of protein synthesis can· be controlled (6) .
We found that ANI is an effective amnestic agent for a variety of passive and active behavioral tasks. The rrost used experimental tasks fall into tv~ broad categories--passive avoidance and active avoidance. Typical passive avoidance tasks are the step-dovm and step-thru tasks. If the animal steps dovm from the platform or steps thru the hole, it receives a slight electrical shock to its feet until it returns (usually very quickly) to its original IX>sition. Typically, only one training trial is required in order that uIX>n a subsequent test some days later, the animal will derronstrate "menory" of the training by not stepping dovm from the platform or by not going thru the hole into another section of the box. An animal that quickly steps down or thru is said to be "amnesic". 'ThlO types of active avoidance training procedures have been used in our studies. In the T-maze, the animal is trained to go to the correct arm (for example, the right arm) to escape or avoid shock. In the IX>le~jump, which also has been frequently used by Prof. DeWied's group, the animal must cling to the wire n~sh on the IX>le to escap2 -or avoid shock. These active avoidance tasks typically are nore difficult for the animal to learn than passive avoidance; frequently, they take 5 or nore training trials (7, 8) .
Using all of these tasks, we showed that ANI was an effective amnestic agent. In addition, in the course of these investigations, we began to appreciate the many factors that can control how well a behavioral task is learned and indirectly the degree of amnesia for that task with a given treatment with ANI. These factors, which n~~ seen rather obvious, include the foll~ing: species and strain of animals, shock intensity, duration of shock, latency of animal to enter shock compartment, number of training trials, interval frem training to testing, and difficulty of behavioral task.
It was found that for a given training task, the greater the training strength, the less the amnesia. It was also found that for a given training strength, the longer the duration of protein synthesis inhibition, the greater the amnesia (4).
From these and other studies we have derived a rather simplistic model of the formation of a menory trace. The general idea is that ~ries of different strengths are formed clOd decay in a manner shc'h'l1 in Fig. 1 \vhich depends Up,~'l many fClctors designated here simply as "trClining stn~ngth."
Time of training
Log ( time ofter training) 4 Fig. 1 . Schematic representation of memory trace formation as a function of training strength. Animals with a training strength near the dividing line between "meoory" and "amnesia" can be used to study the effect of numerous drugs on long-term meoory trace formation. These concepts indicate that the ANI treatment might provide a generally useful and sensitive experimental design to determine the effects of numerous other'drugs on long-term meoory formation. with a suitable program of training and adminis~ tration of ANI we can place the subjects near a "balance point" that is, near the behavioral dividing line which classifies an animal as having either "memory" or "amnesia". Here the effects of the other drug can be measured very sensitively. The general procedure is to administer ANI 15 min prior to training, train the mouse, and at a suitable interval after training administer the drug under investigation, and perhaps administer one or more additional doses of ANI in order to place the "memory strength" near the balance point. A week or so later the animals are tested. This procedure permits the administration of the drug under investigation at an extended time-30 min to 1 hr--after training and thus serves to eliminate possible effects of the drug on the training itself.
Results of an experiment using ANI and d-amphetamine are shown in Fig. 2 . d-Amphetamine administered either 30 or 90 min after training attenuated the amnesic effect of two successive doses of ANI, but if d-amphatamine administration was delayed until 150 min after training, little attenuating effect was seen.
Using this procedure, we have shown that a variety of drugs generally classed as stimulants-nicotine, picrotoxin, d-amphetamine, strychnine, and caffeine--can overcome the amnesia produced by several injections of ANI (8) . It is of interest to note two recent reports of improvement of long-term memory in normal humans by physostigmine, arecholine, and choline (9,10).
On the other hand, depressants had the opposite action; chloral hydrate and phenobarbital administered 30 min after training increased the percentage of amnesic mice (Fig. 3) . Similar results were obtained with meprobamate and chlorpromazine. We believe these data and other data both from our laboratories and those of others are consistent with the hypothesis that the level of arousal following aquisition plays an important role in determining the length of time and the rate of the biosyntiletic phase of memory formation.
While we and several other groups of investigators have interpreted experiments with ANI and cycloheximide as evidence for an essential role of protein in memory storage, other investigators, principally Flexner and coworkers and Quartermain and coworkers, have suggested that side effects of inhibitors of protein synthesis on catecholamine metabolism are the main cause of arrmesia (3, 11, 12) . They point out that administration of protein synthesis inhibitors appears to modify concentrations of catecholamines and that catecholamine inhibitors can produce arrmesia. A further reason for critically determining whether protein synthesis inhibition produces amnesia because of effects on catecholamines comes from observations of Flood.
Flood has recently investigated some 20 drugs that modify neurotransmitterreceptor interaction. These experiments have demonstrated that post-trial administration of drugs that increase catecholamine receptor activity, such as apomorphine, clonidine, ann de sme thyl imipramine imProve retention of a T-maze avoidance task.
Drugs that decrease catecholamine receptor interaction such as pimozide, y-hydroxybutyric acid, and propranolol impair retention. It is concluded that dopamine and norepinephrine are both involved in memory formation (13 ,14) • . We recently have ccmpleted a series of experiments in which the amnesic effects of ANI were compared with those of the catcholamine inhibitors diethyldithiocarba-. roic acid, tetrabenazine, and Cl-methyl-p-tyrosine. 'lbese agents each have rather different effects on cerebral catecholaminesi diethyldithiocarbamate lowers norepinephrine levels in brain by inhibiting dopamine-B-hydroxylase but does not affect serotonin or dopamine; tetrabenazine disrupts storage of dopamine, norepinephrine, norepinephrine, and serotonin, and Cl-methyl-p-tyrosine decreases norepinephrine and dopamine but does not affect serotonin (Fig. 4) . . . The rationale of our experiments was this: If the major cause of the amnesic action of ANI was due to its effects on catecholamines, rather than its actions as an inhibitor of protein synthesis, then catecholamine synthesis inhibitors such as diethyldithiocarbamic acid, tetrabenazine, and Cl-methyl-p-yrosine could be substituted for ANI and should be equally or more effective as amnestic agents. If, however, a correspondence of behavioral effects was not obtained over a 6 variety of experimental paradigms, and if ANI was more effective than the catecholamine inhibitors (CAl's), this would provide strong support for our conclusion that protein synthesis is a necessary and distinct component of long-term memory formation.
In one experiment designed to test the "catecholamine hypothesis", we compared the effectiveness of a series of three injections of each of these drugs in producing amnesia in well-trained mice. A moderately high shock intensity and a step-thru passive avoidance task were used. We have noted earlier that longer inhibition of protein synthesis lends to amnesia even in better trained aniIll:.,h;. 'rne CAl's were first administered 60 min prior to training to allow sufficient time for them to exert their effects on neurotransmitters. ANI was administered 15 min prior to training. We have shown that ANI inhibits brain protein synthesis in less than 5 min (15) . The second and third injections were 2 and 4 hrs after the first. None of the three CAl's was effective as an amnestic agent, whereas extended inhibition of protein synthesis did produce amnesia (Fig. 5) . Thus, this experiment provided clear evidence that inhibition of protein synthesis, achieved by administration of ANI produced amnesia whereas inhibition of catecholamines was ineffective. A further test of the "catecholamine hypothesis" was made as follows: If the the mode of action of ANI as an amnestic agent is a result of its inhibition of catecholamine synthesis, then one should be able to replace one of the series of three ANI injections with an injection of a CAl and still obtain a high percentage of amnesic subjects. TO test this hypothesis, subjects were trained as in the previous experiments on the one-trial passive avoidance task. ANI was administered to all groups (except the saline control) 15 min prior to training. The second injection was either ANI or cycloheximide administered 1 3/4 hr after training, or tetrabenazine, a-methyl-p-tyrosine, diethyldithiocarbarnate or saline 3/4 hr after training. All groups except the saline control received ANI at 3 3/4 hr after training. The CAl's could not be substituted for ANI, while cycloheximide, another protein synthesis inhibitor, could (Fig. 6 ). . with the one-trial passive avoidance task, no amnesia was obtained when a catecholamine inhibitor was substituted for the second of a series of ANI injections. However, amnesia was obtained when cycloheximide, another protein synthesis inhibitor, was substituted for anisc::mycin. (N "" 20/grollp). The results of these and other experiments indicate that: 'tIhile catedl:):l~l~\ine inhibitors can impair long-term memory formation, in a variety of conditions they cannot be substituted for ANI. It is clear that ANI's principal amnestic mechanism does not involve inhibition of the catecholamine system. The results of these I 8 experiments strengthen out cOnclusion that protein synthesis is an essential component for long-term memory trace formation.
At this point, it perhaps is appropriate to speculate and indicate what we believe to be the role of neurotransmitters and proteins for memory. Fig. 7 . A theoretical model for memory storage (16) . In this paper we are concerned primarily with the biochemical steps occurring after the block labeled "Temporary Chemical-Space". Proteins and other macromolecules transported down the axon are thought to lead to long-lasting changes in membranes at the synapse. Let us use a schema proposed by Shashoua some years ago (Fig. 7) (16) . In the lower portion of this schema, we see the neurotransmitters as important at the stage labeled "Temporary Chemical-Space". In the excited neuronal pathways involved in a specific sensory event, the neurotransmitters can modulate the activity of RNA to produce additional proteins in the cell-body. Under the heading of "neurotransmitters" we can include not only the more corrnnon ones we all recognize but also molecules such as ACTH peptides which are usually classed as hormones, and cyclic nucleotides (second messengers). The proteins formed by this activity are then transported down the axons or the dendrites to either synaptic endings or post-synaptic receptors. Ultimately, the transported molecules lead to alteration of synapses and perhaps even formation of new dendritic branching and synaptic endings. In other words, protein synthesized in the neuronal cell body is used, in conjunction with other molecules, to produce permanent and semi-permanent anatomical changes. Evidence is being obtained from many laboratories for the anatanical pL . .
:~,ticity of brain in response to environmental ::;Uiil')ll. 'Thus, the speculations of cajal and those of Katz and Halstead were both concct--learning does modify the brain in ways that can now be measured, both anatomically and biochemically.
